Early Phase Bioassays & Analytics

Bioassays serve as critical tools in the early phases of drug development. These assessments quantify a drug's interaction with biological targets, elucidating its potential efficacy and safety profile. By identifying promising candidates and weeding out unsuitable compounds, bioassays streamline the development process, enabling informed decision-making. This ensures that only the most therapeutically beneficial and safe drugs progress towards clinical trials.

The development of phase-appropriate, tailored bioassays is crucial. Such assays empower researchers to make effective decisions throughout the drug development journey, ultimately accelerating the delivery of life-saving medicines to patients. Our unique approach focuses on developing phase-appropriate assays that are tailored to your program, giving you tools to make effective decisions during your drug development journey to IND and beyond. Learn how Abzena can help you streamline and de-risk your complex biologic or bioconjugate development program.